Literature DB >> 28202819

[MELAS: Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes].

Hidetomo Murakami1, Kenjiro Ono.   

Abstract

Mitochondrial disease is caused by a deficiency in the energy supply to cells due to mitochondrial dysfunction. Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) is a mitochondrial disease that presents with stroke-like episodes such as acute onset of neurological deficits and characteristic imaging findings. Stroke-like episodes in MELAS have the following features: 1) neurological deficits due to localization of lesions in the brain, 2) episodes often accompany epilepsy, 3) lesions do not follow the vascular supply area, 4) lesions are more often seen in the posterior brain than in the anterior brain, 5) lesions spread to an adjacent area in the brain, and 6) neurological symptoms often disappear together with imaging findings, but later relapse. About 80% of patients with MELAS have an A-to-G transition mutation at the nucleotide pair 3243 in the dihydrouridine loop of mitochondrial tRNA<sup>Leu(UUR)</sup>, which causes the absence of posttranscriptional taurine modification at the wobble nucleotide of mitochondrial tRNA<sup>Leu(UUR)</sup> and disrupts protein synthesis. However, the precise pathophysiology of stroke-like episodes is under investigation, with possible hypotheses for these episodes including mitochondrial angiopathy, mitochondrial cytopathy, and neuron-astrocyte uncoupling. With regard to treatment, L-arginine and taurine have recently been suggested for relief of clinical symptoms.

Entities:  

Mesh:

Year:  2017        PMID: 28202819     DOI: 10.11477/mf.1416200650

Source DB:  PubMed          Journal:  Brain Nerve        ISSN: 1881-6096


  3 in total

Review 1.  Cerebral imaging in paediatric mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuroradiol J       Date:  2018-07-06

2.  Heteroplasmy Detection of Mitochondrial DNA A3243G Mutation Using Quantitative Real-Time PCR Assay Based on TaqMan-MGB Probes.

Authors:  Enguang Rong; Hanbo Wang; Shujing Hao; Yuhong Fu; Yanyan Ma; Tianze Wang
Journal:  Biomed Res Int       Date:  2018-11-13       Impact factor: 3.246

Review 3.  Arginine therapy in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.

Authors:  Masamichi Ikawa; Nataliya Povalko; Yasutoshi Koga
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2020-01       Impact factor: 3.620

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.